Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Destiny Pharma's XF-73 Being Studied For Diabetic Foot Ulcers, Burns Too
Sep 27 2018
•
By
Sten Stovall
Destiny Pharma Will Trial XF-73 In Diabetic Foot Ulcers And Burn Wounds • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business